DE60236643D1 - Opiatrezeptoren - Google Patents

Opiatrezeptoren

Info

Publication number
DE60236643D1
DE60236643D1 DE60236643T DE60236643T DE60236643D1 DE 60236643 D1 DE60236643 D1 DE 60236643D1 DE 60236643 T DE60236643 T DE 60236643T DE 60236643 T DE60236643 T DE 60236643T DE 60236643 D1 DE60236643 D1 DE 60236643D1
Authority
DE
Germany
Prior art keywords
nucleic acid
isolated nucleic
opiate receptor
receptor activity
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60236643T
Other languages
English (en)
Inventor
Patrick Cadet
George B Stefano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Original Assignee
Research Foundation of State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of State University of New York filed Critical Research Foundation of State University of New York
Application granted granted Critical
Publication of DE60236643D1 publication Critical patent/DE60236643D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90245—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60236643T 2001-02-22 2002-02-22 Opiatrezeptoren Expired - Lifetime DE60236643D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27047901P 2001-02-22 2001-02-22
US33667701P 2001-12-05 2001-12-05
PCT/US2002/005452 WO2002068594A2 (en) 2001-02-22 2002-02-22 Opiate receptors

Publications (1)

Publication Number Publication Date
DE60236643D1 true DE60236643D1 (de) 2010-07-22

Family

ID=26954322

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60236643T Expired - Lifetime DE60236643D1 (de) 2001-02-22 2002-02-22 Opiatrezeptoren

Country Status (7)

Country Link
US (3) US7094892B2 (de)
EP (1) EP1377826B1 (de)
AT (1) ATE470858T1 (de)
AU (1) AU2002303098A1 (de)
CA (1) CA2439175C (de)
DE (1) DE60236643D1 (de)
WO (1) WO2002068594A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008503228A (ja) * 2004-06-25 2008-02-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 機能スクリーニングアッセイ
WO2007092770A2 (en) * 2006-02-02 2007-08-16 William Marsh Rice University Fabrication de dispositifs electriques par façonnage de nanotubes
US20180137235A1 (en) * 2015-04-28 2018-05-17 Proove Biosciences, Inc. System and method for processing genotype information relating to opioid risk

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5341204A (en) * 1993-06-29 1994-08-23 Grant Engineering, Inc. Shearing optical element for interferometric analysis system
AU3382595A (en) * 1994-07-29 1996-03-04 Smithkline Beecham Corporation Novel compounds
DK0846173T3 (da) * 1995-08-24 2006-01-16 Genaera Corp Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
AU1394899A (en) * 1997-11-10 1999-05-31 Research Foundation Of The State University Of New York, The Opiate, cannabinoid, and estrogen receptors
AU5102799A (en) * 1998-07-16 2000-02-07 Memorial Sloan-Kettering Cancer Center Multiple splice variants of the mu-opioid receptor gene
FI982796A (fi) 1998-12-23 2000-06-24 Nokia Networks Oy Tiedonsiirron tehostaminen

Also Published As

Publication number Publication date
EP1377826A4 (de) 2006-11-29
US20030054451A1 (en) 2003-03-20
CA2439175C (en) 2014-05-06
US20080182316A1 (en) 2008-07-31
AU2002303098A1 (en) 2002-09-12
US7094892B2 (en) 2006-08-22
US7285655B2 (en) 2007-10-23
EP1377826A2 (de) 2004-01-07
WO2002068594A2 (en) 2002-09-06
ATE470858T1 (de) 2010-06-15
WO2002068594A3 (en) 2003-05-30
EP1377826B1 (de) 2010-06-09
US7671176B2 (en) 2010-03-02
CA2439175A1 (en) 2002-09-06
US20060229444A1 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
SG158736A1 (en) Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
IL168050A (en) Il-1 receptor based antagonists and methods of making them and reagents for use therein
NO20011513D0 (no) Reseptor-baserte antagonister samt fremgangsmÕte ved fremstilling og anvendelse derav
GEP20094629B (en) Nogo receptor binding protein
BRPI0413426A (pt) antagonistas de receptor novo
ATE490323T1 (de) Adiponektin-rezeptor und dafür kodierendes gen
WO2000015793A3 (en) Human gpcr proteins
WO2005028497A3 (en) Receptor binding peptides derived from the sars s protein
WO2003027228A3 (en) Receptors and membrane-associated proteins
WO2003048305A3 (en) Receptors and membrane-associated proteins
WO2003002604A3 (en) G protein coupled receptors and dna sequences thereof
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
WO2001005970A3 (en) Gtp-binding protein associated factors
WO2002102839A3 (en) Novel g-protein coupled receptors and dna sequences thereof
WO1999024587A3 (en) Human phospholipase a2 protein and dna encoding it
DE60236643D1 (de) Opiatrezeptoren
WO2000020590A3 (en) G-protein coupled receptor proteins
WO2003070902A3 (en) Receptors and membrane-associated proteins
WO2002094990A3 (en) Receptors and membrane-associated proteins
WO2003044162A3 (en) Genes encoding g-protein coupled receptors and methods of use therefor
WO2005042717A3 (en) Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
WO2000065054A3 (en) Human membrane-associated proteins
WO2004100774A3 (en) Receptors and membrane-associated proteins
WO2003025130A3 (en) Receptors and membrane-associated proteins
WO2004009770A3 (en) Methods and compositions for modulating agonist-induced downregulation of g protein-coupled receptors